Seeking Alpha

NPS Pharmaceuticals (NPSP +5.4%) clocks a gain a day after announcing it completed its...

NPS Pharmaceuticals (NPSP +5.4%) clocks a gain a day after announcing it completed its submission to the FDA for its experimental Gattex drug - a hopeful sign which follows the firm reporting "adverse events" in October with trials.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs